Efficacy, safety, tolerability and quality of life of ongoing individually optimized lipid-lowering therapy with or without inclisiran (KJX839) – a randomized, placebo-controlled, double-blind multicenter phase IV study in participants with hypercholesterolemia

This study is looking into new ways to help people who have high cholesterol. You might know cholesterol as the 'waxy' substance in your blood. While some cholesterol is good for you, too much of a certain type, often called 'bad' cholesterol (LDL-C), can build up in your arteries and cause serious health problems like heart attacks and strokes. So, keeping your cholesterol at a healthy level is really important.

Doctors already have medicines like 'statins' (you might have heard of Rosuvastatin) that work well to lower cholesterol. This study is trying to understand if adding a new medicine called Inclisiran to these existing treatments could be even better. Imagine your current cholesterol medication is like a strong defence; this study wants to see if Inclisiran can be an extra, powerful player on the team. They want to check if it helps more people reach their personal cholesterol targets, and if it makes them feel better overall, without causing new problems.

The main goal is to see how many people can get their 'bad' cholesterol down to a healthier level, which might be less than 55 mg/dL or less than 70 mg/dL, depending on what's right for them. The study also looks closely at whether people experience side effects, especially muscle pain, and how their general well-being and daily activities are affected. This kind of research helps doctors understand the best ways to keep people with high cholesterol healthy and feeling good.